Elaine Del Bel

Has grant

Professor

University of Sao Paulo
Country flagBrazil

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Contribution of the neuroinflamation to L-DOPA induced dyskinesia

Open Date: 2016-04-01

Close Date: 2019-03-31

Grant: Close

Analysis of nitric oxide synthase in dopaminergic and non dopaminergic neurons in experimental Parkinson Disease: role of NOS inhibitors in L-DOPA induced diskinesias

Open Date: 2009-01-01

Close Date: 2013-03-31

Grant: Close

Complementação da estruturação para autonomia de consórcio de laboratórios do Departamento de Morfologia Estomatologia e Fisiologia da Faculdade de Odontologia de Ribeirão Preto da Universidade de São Paulo

Open Date: 2005-09-01

Close Date: 2008-05-31

Grant: Close

Análise da recuperação neural após lesão

Open Date: 2001-05-01

Close Date: 2003-07-31

Grant: Close

Plasticidade neuronal em resposta a estressores: alterações moleculares e comportamentais

Open Date: 1996-08-01

Close Date: 2000-09-30

Articles (13)

Year:

2024

Year:

2024

Year:

2024

To study the anti‐inflammatory potential of the two synthetic cannabinoids 4′‐F‐CBD and HU‐910, we used post‐natal brain cultures of mouse microglial cells and astrocytes activated by reference inflammogens. We found that 4′‐F‐CBD and HU‐910 efficiently curtailed the release of TNF‐α, IL‐6, and IL‐1β in microglia and astrocytes activated by the bacterial Toll‐Like Receptor (TLR)4 ligand LPS. Upon LPS challenge, 4′‐F‐CBD and HU‐910 also prevented the activation of phenotypic activation markers specific to microglia and astrocytes, that is, Iba‐1 and GFAP, respectively. In microglial cells, the two test compounds also efficiently restrained LPS‐stimulated release of glutamate, a non‐cytokine inflammation marker for these cells. The immunosuppressive effects of the two cannabinoid compounds were concentration‐dependent and observable between 1 and 10 μM. These effects were not dependent on cannabinoid or cannabinoid‐like receptors. Both 4′‐F‐CBD and HU‐910 were also capable of restraining the inflammogenic activity of Pam3CSK4, a lipopeptide that activates TLR2, and of BzATP, a prototypic agonist of P2X7 purinergic receptors, suggesting that these two cannabinoids could exert immunosuppressive effects against a variety of inflammatory stimuli. Using LPS‐stimulated microglia and astrocytes, we established that the immunosuppressive action of 4′‐F‐CBD and HU‐910 resulted from the inhibition of ROS produced by NADPH oxidase and subsequent repression of NF‐κB‐dependent signaling events. Our results suggest that 4′‐F‐CBD and HU‐910 may have therapeutic utility in pathological conditions where neuroinflammatory processes are prominent.

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Alexander Birbrair

Tenure-track Assistant Professor

University of Wisconsin-Madison

UNITED STATES
View details

Samia Joca

VIP, Associate Professor

Aarhus University

DENMARK
View details

Jean Michel Brunel

Aix-Marseille University

FRANCE
View details

Ana González-Cuello

Senior Lecturer

Universidad de Murcia

SPAIN
View details

Pilar Almela

Associate Professor

Universidad de Murcia

SPAIN
View details

María-Trinidad Herrero

Directora de la Cátedra de Comunicación Sanitaria

Universidad de Murcia

SPAIN
View details

Maurício dos-Santos-Pereira

Assistant Professor

University of Sao Paulo

BRAZIL
View details

Nicole Rodrigues

Assistant Professor

Aarhus University

DENMARK
View details

Glauce Crivelaro Nascimento

Professor

University of Sao Paulo

BRAZIL
View details

Rita Raisman-Vozari

Directeur de Recherche

CNRS Délégation Paris B

FRANCE
View details

Pedro Gobira

Assistant Professor

Aarhus University

DENMARK
View details

Patrick Pierre Michel

Senior PI

Institut du Cerveau et de la Moelle Épinière

FRANCE
View details